BridgeMD
New treatment option for Schizophrenia
Official title Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses
ClinicalTrials.gov ID: NCT06613334
What this study is testing
What is Blood test: measurement of plasma antipsychotic concentration?
Blood test: measurement of plasma antipsychotic concentration is an investigational medicine, given as an once-daily, being studied as a potential treatment for schizophrenia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Schizophrenia is a serious psychiatric illness affecting approximately 25 million people worldwide. Patients with schizophrenia experience hallucinations, auditory illusions, disordered thinking, movement disorders, cognitive impairment and social isolation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Affiliated to a social security or other social protection scheme
- Diagnosed with schizophrenia according to the DSM-5 (code F20)
- Stable state without duration criteria
- Main treatment with risperidone or paliperidone, aripiprazole, olanzapine in oral or long-acting injectable form
- Complementary treatment with an antipsychotic for anxiolytic or sedative purposes: chlorpromazine, loxapine or cyamemazine
You likely can't join if
- Suffering from a pathology that impairs French
- Suffering from a neurological pathology: multiple sclerosis, Parkinson's disease, Huntington's disease or neurodegenerative disease
- Treatment with lithium salts
- Anti-epileptic treatment
- Participant in another study involving medication
See the full eligibility criteria
- Affiliated to a social security or other social protection scheme
- Diagnosed with schizophrenia according to the DSM-5 (code F20)
- Stable state without duration criteria
- Main treatment with risperidone or paliperidone, aripiprazole, olanzapine in oral or long-acting injectable form
- Complementary treatment with an antipsychotic for anxiolytic or sedative purposes: chlorpromazine, loxapine or cyamemazine
- Able to speak and read French
- Able to perform speech evaluations
- Able to answer questionnaires on smartphone
- May be under curatorship or guardianship
- Agreeing to participate in the study and with informed consent signed by the subject, as well as by the legal representative in the case of a person under curatorship or guardianship
- Suffering from a pathology that impairs French
- Suffering from a neurological pathology: multiple sclerosis, Parkinson's disease, Huntington's disease or neurodegenerative disease
- Treatment with lithium salts
- Anti-epileptic treatment
- Participant in another study involving medication
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Paris, France
- Paris, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Paris, France; Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.